Raphael Rousseau serves as Executive at Gritstone Oncology, Inc., where they oversee executive responsibilities. Since joining the company, Raphael Rousseau has executed 9 insider transactions totaling $735.0K, demonstrating a bearish approach to their equity position. Their most recent transaction on May 27, 2021 involved exercising options for 2,900 shares valued at $2.2K.
Raphael Rousseau currently holds 2,900 shares of Gritstone Oncology, Inc. (GRTS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Raphael Rousseau has been a net seller of GRTS stock. They have purchased $0 and sold $735.0K worth of shares.
Raphael Rousseau's most recent insider trade was on May 27, 2021, when they sold 2,900 shares at $0.76 per share.
Get notified when new Form 4 filings are submitted
| $9.00 |
| Discretionary |
| Jan 20, 2021 | GRTS | $7.6K | Option Exercise | 10,000 | $0.76 | Discretionary |
| Jan 20, 2021 | GRTS | $250.7K | Sale | 10,000 | $25.07 | Discretionary |
| Jan 19, 2021 | GRTS | $15.2K | Option Exercise | 20,000 | $0.76 | Discretionary |
| Jan 19, 2021 | GRTS | $350.6K | Sale | 20,000 | $17.53 | Discretionary |
| Jan 7, 2021 | GRTS | $0 | Award | 29,700 | $N/A | Discretionary |
| Aug 21, 2019 | GRTS | $7.6K | Option Exercise | 10,000 | $0.76 | Discretionary |
| Aug 21, 2019 | GRTS | $107.6K | Sale | 10,000 | $10.76 | Discretionary |